Search clinical trials for: (3-aminopropyl)(n-butyl)phosphinic acid

Total 223 results

Mario Negri Institute for Pharmacological Research

Completed

Risk and Prevention Study: Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk

Cardiovascular Diseases

Italy
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Withdrawn

Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer

Stage III Prostate Cancer
University of Missouri-Columbia

Suspended

n-3 Polyunsaturated Fatty Acids to Prevent and Treat Diabetic Neuropathy (NMF)

Diabetic Neuropathies

United States
Aalborg University Hospital

Completed

Marine n-3 Polyunsaturated Fatty Acids in Pre- and Postmenopausal Women

Postmenopause | Premenopause

Denmark
New Mexico Cancer Care Alliance
Alliance Healthcare Foundation

Completed

Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel

Pain | Breast Cancer | Ovarian Neoplasm

United States
University College Dublin

Completed

Novel Nutrition Solutions for Sarcopenia (NUTRIMAL)

Sarcopenia

Ireland
Medical University of Vienna
National Bank of Austria

Completed

n-3 Polyunsaturated Fatty Acids in Obesity (PUFA-ATI)

Morbid Obesity | Adipose Tissue Inflammation

Austria
Taipei City Psychiatric Center, Taiwan
National Science Council, Taiwan

Completed

Fish Oil Supplementation in Late-life Depression

Late-Life Depression

Taiwan
University of Dundee

Withdrawn

Omega 3 Polyunsaturated Fatty Acid Supplements (PUFAs) and Microvolt T Wave Alternans (TWA) in Patients With Ventricular Arrhythmia

Arrhythmia | Defibrillators, Implantable

United Kingdom
Yonsei University

Completed

n-3 Fatty Acids in Enteral Formula on NK Cell Activity (YS)

Enteral Nutrition
Radboud University Medical Center

Completed

Immune Modulation by Parenteral Fish Oil in Patients With Crohn's Disease

Crohn Disease

Netherlands
OHSU Knight Cancer Institute
National Cancer Institute (NCI); United States Department of Defense

Completed

Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer

Prostate Cancer | Precancerous Condition

United States
Federico II University

Completed

n-3 Polysaturated Fatty Acids-rich Diet in Psoriasis (PSO)

Plaque-type Psoriasis | Obesity (Body Mass Index >30 kg/m2)

Italy
Sidney Kimmel Cancer Center at Thomas Jefferson...

Active, not recruiting

2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies

Hematopoietic and Lymphoid Cell Neoplasm

United States
GCP-Service International West GmbH
Charite University, Berlin, Germany; Wuerzburg University Hospital

Recruiting

Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients. (MODIFYCSX)

Cardiac Surgery | Cardiopulmonary Bypass | Intensive Care Unit | High Risk Patients | Valve Surgeries

Germany
Pfizer

Completed

Single Dose Study To Study The Absorption, Metabolism And Excretion Of PF-04991532

Healthy

United States
University of Colorado, Denver

Active, not recruiting

Window of Opportunity Study Targeting the Inflammatory Milieu

Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Recurrent Mantle Cell Lymphoma

United States
Universidade Estadual de Maringá

Unknown

Efficacy of N-Acetyl-Cysteine in Bipolar Disorder and Tobacco Use Disorder (NACBD)

Bipolar Disorder

Brazil
National Cancer Institute (NCI)
NRG Oncology

Completed

Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous... and other conditions

United States
Emory University
National Cancer Institute (NCI); Janssen Scientific Affairs, LLC

Recruiting

Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure

Renal Failure | Plasma Cell Myeloma

United States
University of North Carolina, Chapel Hill

Terminated

Vitamin D and n-3 Polyunsaturated Fatty Acids (PUFAs) to Prevent Chronic Pain Following Major Thermal Burn Injury

Chronic Pain Following Thermal Burn Injury

United States
Copenhagen Studies on Asthma in Childhood

Active, not recruiting

Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood

Asthma | Allergy | Eczema

Denmark
National Cancer Institute (NCI)

Completed

Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast Carcinoma

United States
Quest PharmaTech Inc.

Completed

A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer

Ovarian Neoplasms

United States
National Cancer Institute (NCI)

Completed

Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Therapy-Related Acute Myeloid Leukemia

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
National Cancer Institute (NCI)

Completed

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

Follicular Lymphoma | Myeloid Leukemia | Polycythemia Vera | Hodgkin Lymphoma | Myelofibrosis | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Chronic Lymphocytic Leukemia | Secondary Acute Myeloid Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Refractory... and other conditions

United States
National Cancer Institute (NCI)

Active, not recruiting

Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Acute Myeloid Leukemia Post Cytotoxic Therapy

United States
Sanjay Gandhi Postgraduate Institute of Medical...

Unknown

Frequency of Sleep Abnormalities in Patients With Irritable Bowel Syndrome and Effect of Pharmacological Intervention

Irritable Bowel Syndrome

India
Sixth Affiliated Hospital, Sun Yat-sen University

Not yet recruiting

N-3 Polyunsaturated Fatty Acids Prevent Postoperative Recurrence of Crohn's Disease

Inflammatory Bowel Diseases | Crohn Disease | Polyunsaturated Acid Lipidosis
University of Oxford
Bayer; Medical Research Council; Abbott; British Heart Foundation; Solvay Pharmaceuticals and other collaborators

Active, not recruiting

ASCEND: A Study of Cardiovascular Events iN Diabetes

Diabetes Mellitus

United Kingdom
Massachusetts General Hospital

Recruiting

A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth

Mood Disorders | Mood Disturbance | Alternative Treatment | Natural Supplements

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
Massachusetts General Hospital
Demarest Lloyd Jr. Foundation

Recruiting

Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)

Autism Spectrum Disorder | Autism | Non-verbal Learning Disorder

United States
Universidad Autonoma de San Luis Potosí
Hospital Central "Dr. Ignacio Morones Prieto"

Completed

Ultraviolet and UV-Visible Light Photoprotection for the Treatment of Melasma

Melasma

Mexico
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery

Pancreatic Adenocarcinoma | Unresectable Pancreatic Carcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
Hospital de Granollers

Completed

Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC

HIV Infections

Spain
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Lenalidomide, Thalidomide and Dexamethasone in Treating Participants With Relapsed or Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
Agricultural University of Athens

Completed

Short-term Effects of Juice Consumption With Biofunctional Compounds and Probiotics on Subjective Appetite

Subjective Appetite

Greece
Massachusetts General Hospital
National Institute on Aging (NIA)

Unknown

The Effects of Aging and Estrogen on the Pituitary

Healthy

United States
University of Iowa
DJO Incorporated; Direct MS Canada; Pinnaclife Inc.; TZ Press, LLC

Completed

Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)

Multiple Sclerosis

United States
Ohio State University Comprehensive Cancer Center
Cancer and Leukemia Group B

Completed

Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
Massachusetts General Hospital
National Institutes of Health (NIH)

Unknown

Letrozole Treatment in Normal and GnRH Deficient Women

Healthy Volunteers

United States
National Cancer Institute (NCI)

Active, not recruiting

Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma

United States, Israel
National Cancer Institute (NCI)

Active, not recruiting

Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma

DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple Myeloma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Not yet recruiting

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

Metastatic Osteosarcoma | Localized Osteosarcoma | Unresectable Osteosarcoma | Resectable Osteosarcoma
National Cancer Institute (NCI)

Completed

Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma

DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
GlaxoSmithKline

Withdrawn

Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)

Venous Thromboembolism

United States
State University of New York at Buffalo

Not yet recruiting

Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC

Carcinoma, Renal Cell

Search clinical trials for: (3-aminopropyl)(n-butyl)phosphinic acid

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations